Rang	Name	Position
1	Mr. Robert M. Davis J.D.	Chairman, President & CEO
2	Ms. Caroline A. Litchfield	Executive VP & CFO
3	Ms. Jennifer L. Zachary J.D.	Executive VP & General Counsel
4	Dr. Dean Y. Li M.D., Ph.D.	Executive VP & President of Merck Research Laboratories
5	Mr. Dalton E. Smart III	Senior VP of Finance, Principal Accounting Officer & Global Controller
6	Mr. Gaurav K. Gupta	Executive Vice President and Chief Information & Digital Officer
7	Mr. Peter Dannenbaum	Vice President of Investor Relations
8	Mr. Chirfi Guindo	Executive Vice President of Strategic Access, Policy & Communications
9	Ms. Betty D. Larson	Executive VP & Chief Human Resources Officer
10	Mr. Richard R. DeLuca Jr.	Executive VP & President of Merck Animal Health

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	9,20%	31,99 Mrd. USD
2	Vanguard Capital Management, LLC	6,54%	22,74 Mrd. USD
3	State Street Corp	4,88%	16,97 Mrd. USD
4	Wellington Management Company LLP	3,50%	12,16 Mrd. USD
5	Vanguard Portfolio Management, LLC	2,75%	9,55 Mrd. USD
6	Geode Capital Management, LLC	2,46%	8,56 Mrd. USD
7	Charles Schwab Investment Management Inc	2,20%	7,66 Mrd. USD
8	Morgan Stanley - Brokerage Accounts	1,97%	6,86 Mrd. USD
9	FMR Inc	1,84%	6,40 Mrd. USD
10	JPMorgan Chase & Co	1,78%	6,19 Mrd. USD
11	Fisher Asset Management, LLC	1,56%	5,43 Mrd. USD
12	NORGES BANK	1,50%	5,21 Mrd. USD
13	Bank of America Corp	1,24%	4,30 Mrd. USD
14	Northern Trust Corp	1,07%	3,70 Mrd. USD
15	The Goldman Sachs Group Inc	0,89%	3,11 Mrd. USD
16	Franklin Templeton Inc	0,79%	2,76 Mrd. USD
17	UBS Asset Mgmt Americas Inc	0,79%	2,76 Mrd. USD
18	Legal & General Group PLC	0,77%	2,66 Mrd. USD
19	Amvescap Plc.	0,75%	2,62 Mrd. USD
20	T. Rowe Price Associates, Inc.	0,75%	2,61 Mrd. USD